Halozyme Therapeutics Inc (HALO)

[biotechinvestor1]

Don’t get all too excited, shorts. Read the MS article Maumer cited in his post. It reads:

“…the potential to extend
the exclusivity period from the composition of matter patent from 2031 to
2036.”

The combination of matter patent is well and good at least until 2031. What’s at steak is between 2031 and 2036.

All dips are fantastic buying opportunities as they have been for years purely based on superb fundamentals and valuation.